Introduction {#s1}
============

Asparagine (N)-linked glycosylation (ALG) of proteins is the most common co- and post-translational modification of proteins entering the secretory pathway. N-Glycosylation plays an important role for many biological processes including protein folding, glycan-dependent quality control processes in the ER, protein stability and protein--protein interactions ([@CWW023C82]; [@CWW023C39]). To date, more than thousand different N-glycosylated proteins have been identified with high confidence in the model plant *Arabidopsis thaliana* ([@CWW023C149]; [@CWW023C116]). These proteins have a confirmed or predicted location in the secretory pathway and carry one or several *N*-glycans. The number of glycoproteins and identified glycosylation sites appear similar to animal model species like *Drosophila melanogaster* and *Danio rerio* ([@CWW023C149]). In contrast to mammals, however, plants produce oligosaccharides of reduced complexity and diversity as they lack, for example, branched and sialylated *N*-glycans (Figure [1](#CWW023F1){ref-type="fig"}A). Based on findings from *A. thaliana* ([@CWW023C140]; [@CWW023C118]), it has been hypothesized that complex *N*-glycans are not essential for the development and reproduction of plants when grown under standard environmental conditions. Strikingly, however, all of the characteristic complex *N*-glycan modifications (β1,2-Xyl, core α1,3-Fuc and Lewis A-type structures) are conserved in higher plants and even found in distantly related mosses like *Physcomitrella patens* ([@CWW023C28]; [@CWW023C143]; [@CWW023C137]), suggesting that there are evolutionary constraints that prevent the loss of these *N*-glycan modification. For a long time, it remained obscure why plants produce distinct complex *N*-glycans at all and whether there is any specific function related to complex *N*-glycan modifications ([@CWW023C67]). This review focuses on recent findings concerning the biological role of oligomannosidic and complex *N*-glycans in different plants. Fig. 1.Comparison of different types of protein linked glycans. (**A**) Typical *N*-glycan structures from mammals, plants, insects and yeast (*S. cerevisiae*) are shown. The symbols for the monosaccharides in the illustration are drawn according to the nomenclature from the Consortium for Functional Glycomics. (**B**) Schematic representation of characteristic *O*-glycans from mammals (di-sialylated core 1), plants (extensin-type modification on Ser and contiguous hydroxyproline (Hyp) residues, the structure is drawn according to [@CWW023C85]) and *S. cerevisiae*. The carbohydrate structure of an *A. thaliana* arabinogalactan-protein is not shown here and can be found in [@CWW023C133]. (**C**) The conserved core glycan structure of the GPI-anchor is shown as well as examples derived from a human GPI-anchored protein ([@CWW023C61]) and from pear cells ([@CWW023C91]). P-Et indicates the phsphoethanolamine linkage. This figure is available in black and white in print and in color at *Glycobiology* online.

Apart from N-glycosylation other types of protein glycosylation have been described in plants. Similar to mammals, the transfer of a single GlcNAc to Ser/Thr residues (O-GlcNAcylation) of cytosolic or nuclear proteins appears to play an important role in cellular signaling ([@CWW023C90]). O-Glycosylation, another major type of protein glycosylation, is fundamentally different in plants (Figure [1](#CWW023F1){ref-type="fig"}B). Mucin-type *O*-glycans have not been detected on native plant proteins and the glycosyltransferases for initiation and elongation of mucin-type *O*-glycans have not been found in the plant genomes. In plants, on the other hand, a single Gal can be transferred to Ser residues on specific proteins and arabinose chains as well as structurally complex arabinogalactans occur on hydroxyproline residues of cell wall proteins ([@CWW023C131]; [@CWW023C133]; [@CWW023C105]). A bioinformatics approach has identified 166 hydroxyproline-rich glycoproteins including 85 putative arabinogalactan proteins ([@CWW023C113]). Aspects of their biosynthesis and functions have been summarized in recent reviews and are not further addressed here ([@CWW023C129]; [@CWW023C42]; [@CWW023C85]). In yeast, O-mannosylation in the endoplasmic reticulum (ER) plays an important role for protein folding and quality control ([@CWW023C144]). This and other types of *O*-glycan modifications have also not been detected on plant secretory or membrane proteins. However, the recent identification of the ER-resident nucleotide sugar transporter ROCK1 in *A. thaliana* hints that an unknown protein glycosylation modification might exist in plants with a similar role in protein quality control ([@CWW023C87]). Using transport assays in yeast, it has been shown that ROCK1 transports mainly the nucleotide sugars UDP-GalNAc and UDP-GlcNAc. In *A. thaliana* this transport activity is apparently involved in the regulation of the plant response to the hormone cytokinin. How this is achieved and whether it requires an as yet undiscovered protein glycosylation in the ER of plants remains to be shown in the future.

The attachment of a glycosylphoshatidylinositol (GPI) anchor to the C-terminus of proteins is another common protein modification in the ER of plants. A combination of proteome analysis and bioinformatic search in the *A. thaliana* genome identified 248 putative GPI-anchored proteins ([@CWW023C13]). The GPI-anchor is synthesized by a stepwise process involving a conserved protein machinery and transferred *en bloc* to the protein by the GPI-transamidase complex ([@CWW023C61]). The core glycan structure found in all eukaryotic GPI-anchors comprises Manα(1--2)Manα(1--6)Manα(1--4)GlcN-inositol (Figure [1](#CWW023F1){ref-type="fig"}C). In many eukaryotes, the core glycan can be further modified by incorporation of different sugars including Man and GalNAc. The glycan composition of only one GPI-anchor has been determined in plants to date. The GPI-anchored arabinogalactan-protein derived from a *Pyrus communis* cell suspension culture carried the conserved core oligosaccharide that was partially modified with a β1--4Gal residue ([@CWW023C91]). Whether the glycan moiety of plant GPI-anchored proteins displays species-, cell-type- and protein-specific variations remain to be shown in the future. Putative plant orthologs of the different GPI biosynthesis proteins have been identified in *A. thaliana* and rice ([@CWW023C23]; [@CWW023C24]), but most of them have not been functionally characterized. Heterozygous mutants lacking the putative *A. thaliana* GPI-GlcNAc transferases (SETH1: a homolog of mammalian PIG-C and SETH2: a homolog of mammalian PIG-A) showed male-specific defects in fertility ([@CWW023C63]). Likewise, plants with a disrupted homolog of the mammalian α1,4-mannosyltransferase PIG-M (termed PEANUT1) displayed reduced amounts of GPI-anchored proteins and were seedling lethal ([@CWW023C33]). In a recent study, a mutation in the *A. thaliana* homolog of the α1,2-mannosyltransferase PIG-B (termed APTG1) was found to display similar phenotypes with abnormal male fertility and embryo lethality ([@CWW023C20]). Together, these studies highlight that correct GPI-core oligosaccharide assembly is essential for the vegetative and reproductive development of plants.

Assembly of lipid-linked *N*-glycans in plants {#s2}
==============================================

In all eukaryotes, a hallmark of N-glycosylation is the *en bloc* transfer of the pre-assembled Glc~3~Man~9~GlcNAc~2~ oligosaccharide from the lipid carrier dolichol pyrophosphate to selected asparagine residues in the sequence Asn-X-Ser/Thr (X can be any amino acid except proline) within nascent polypeptides. The enzymatic steps leading to the biosynthesis of the lipid-linked precursor appear the same in plants (Figure [2](#CWW023F2){ref-type="fig"}A). All known yeast ALG proteins are encoded by plant genomes ([@CWW023C65]) and *A. thaliana* mutants with defects in different steps of the lipid-linked oligosaccharide assembly pathway have been described. Loss of ALG3 ([@CWW023C41]; [@CWW023C54]), ALG12 ([@CWW023C43]) and ALG9 ([@CWW023C44]) function is well tolerated by the plants and does not cause any growth or developmental phenotype. In contrast, ALG11 null mutants are lethal ([@CWW023C147]) and plants with ALG10 deficiency display reduced glycosylation efficiency and a leaf growth defect ([@CWW023C27]). The topology of the ALG proteins and their site of action (cytosolic side or ER-lumen) have not been studied in detail in plants. Based on the overall conservation of the pathway, it is expected that ALG11 is active at the cytosolic side of the ER and transfers two consecutive α1,2-linked Man residues to the lipid-linked oligosaccharide. The resulting Man~5~GlcNAc~2~-PP-Dol is then very likely transported across the ER membrane by a flippase-like protein and used as substrate in the ER lumen by ALG3, ALG9, ALG12 and the three glucosyltransferases (ALG6, ALG8 and ALG10). Fig. 2.(**A**) ALG proteins involved in lipid-linked oligosaccharide precursor biosynthesis. Genetic evidence for their function has been shown for the *A. thaliana* glycosyltransferases highlighted in a different color. (A), (B) and (C) define the different branches of the oligosaccharide. (**B**) Illustration of the putative plant OST complex consisting of different subunits. The proposed topology of the enzymes is depicted. Please note that for some proteins like STT3A/STT3B the exact number of transmembrane domains is unclear ([@CWW023C62]) and may range from 10 to 14 helices. The different colors of the transmembrane domains denote subcomplexes that have been described for the yeast and mammalian OST complex ([@CWW023C58]). This figure is available in black and white in print and in color at *Glycobiology* online.

The plant oligosaccharyltransferase complex {#s3}
===========================================

The *en bloc* transfer of the pre-assembled oligosaccharide to an asparagine residue in the canonical N-glycosylation acceptor site takes place in the lumen of the ER and is catalyzed by the oligosaccharyltransferase (OST) complex. The use of alternative N-glycosylation sites like Asn-X-Cys is possible in plant cells ([@CWW023C77]), but has not been described for endogenous plant proteins ([@CWW023C150]). In yeast and mammals, OST is a heteromeric membrane-bound protein complex consisting of one catalytically active subunit (staurosporine and temperature sensitivity 3, STT3) and several different non-catalytic subunits that modulate N-glycosylation by regulation of the substrate specificity, stability or assembly of the complex ([@CWW023C58]; [@CWW023C80]). The yeast OST complex is composed of a single STT3 protein and seven additional subunits ([@CWW023C58]). In metazoans, the organization of the OST complex appears more complex and different subunit compositions have been proposed ([@CWW023C112]; [@CWW023C80]; [@CWW023C101]). Notably, mammals harbor two different catalytic isoforms (STT3A and STT3B) that are present in distinct OST complexes ([@CWW023C103]; [@CWW023C115]; [@CWW023C114]). The mammalian STT3A- and STT3B-containing complexes have overlapping as well as isoform-specific functions and differ in their acceptor substrate selectivity. While human STT3A is predominately involved in co-translational glycosylation, STT3B displays a preference for post-translational glycosylation.

The transfer of the pre-assembled oligosaccharide in plants involves a similar OST multi-subunit complex (Figure [2](#CWW023F2){ref-type="fig"}B), which is still poorly characterized. In *A. thaliana* two proteins, termed STT3A and STT3B, with homology to the yeast and mammalian catalytic subunits have been identified ([@CWW023C62]) (Table [I](#CWW023TB1){ref-type="table"}). STT3A-deficient plants are viable, but display a protein underglycosylation defect that affects the biogenesis of heavily glycosylated proteins, such as the pattern recognition receptor EF-TU RECEPTOR (EFR) ([@CWW023C84]; [@CWW023C104]; [@CWW023C38]). In contrast, STT3B-deficiency does not lead to any obvious changes in N-glycosylation efficiency and EFR function is not compromised ([@CWW023C62]; [@CWW023C84]; [@CWW023C38]). Even though, the *A. thaliana* STT3B subunit is more closely related to human STT3A than to human STT3B, no substrate has yet been identified for STT3B. However, *A. thaliana stt3a stt3b* double knockout plants are gametophytic lethal ([@CWW023C62]). These data highlight the importance of the catalytic OST subunits for N-glycosylation of plant proteins and reveal that the two putative catalytic subunits have overlapping as well as substrate-specific functions. Homologs of the two different *A. thaliana* STT3 subunits are also found in many other plant species, indicating that plants have also two functionally distinct OST complexes. Table I.Putative subunits of the *A. thaliana* OST complex*A. thaliana*\
OST subunitLocus*S. cerevisiae* homologAmino acid identity in % to the yeast subunitReferenceDGL1At5g66680Wbp1p25[@CWW023C68]STT3A\
STT3BAt5g19690\
At1g34130Stt3p\
Stt3p47\
49[@CWW023C62]\
[@CWW023C62]OST1A\
OST1BAt2g01720\
At1g76400Ost1p\
Ost1p23\
24HAP6At4g21150Swp1p25[@CWW023C52]DAD1\
DAD2At1g32210\
At2g35520Ost2p\
Ost2p36\
36[@CWW023C31]\
[@CWW023C21]OST4A\
OST4BAt3g12587\
At5g02502Ost4p\
Ost4p31\
26[@CWW023C26]OST3/6\
OST3/6-LIKE1At1g61790\
At1g11560Ost3p/Ost6p\
Ost3p/Ost6p\<17\
\<17[@CWW023C26]\
[@CWW023C26][^1]

In another study, it has been shown that depletion of *A. thaliana* defective glycosylation 1 (DGL1), a homolog of the essential yeast subunit wheat germ agglutinin binding protein 1 (Wbp1p), is embryo lethal ([@CWW023C68]). Consistent with a role in N-glycosylation, an *A. thaliana* mutant with a weak *dgl1* allele displays reduced protein N-glycosylation occupancy and a partial loss-of-function mutation in the gene coding for rice DGL1 causes defects in root formation ([@CWW023C68]; [@CWW023C96]). The *A. thaliana* homolog (OST3/6) of yeast Ost3p/Ost6p is required for efficient N-glycosylation of EFR ([@CWW023C26]) and together with STT3A OST3/6 is involved in a specific plant cell death response ([@CWW023C22]). Yet, the precise molecular function of OST3/6 and the role of the related OST3/6-LIKE1 in N-glycosylation of plants remain to be established. Whether these proteins either have an oxidoreductase activity or bind to the polypeptide substrates like it has been proposed for the yeast proteins is unclear ([@CWW023C111]; [@CWW023C50]). A preliminary biochemical characterization suggests that OST3/6, STT3A and OST4B, a homologue of the yeast Ost4p subunit, interact *in planta* and form an OST sub-complex similar to that of *Saccharomyces cerevisiae* ([@CWW023C60]; [@CWW023C26]).

Additional *A. thaliana* proteins like hapless 6 (HAP6) and defender against apoptotic cell death 1/2 (DAD1/DAD2) have been identified (Table [I](#CWW023TB1){ref-type="table"}), which are putative orthologs of yeast suppressor of Wbp1 (Swp1p)/mammalian ribophorin II and OST2/DAD1, respectively ([@CWW023C31]; [@CWW023C21]; [@CWW023C52]). *Arabidopsis thaliana* DAD1 can rescue the apoptotic phenotype of a mutant hamster cell line indicating a conserved function between animals and plants ([@CWW023C31]). However, a specific role in N-glycosylation has yet to be revealed for DAD1/DAD2 and HAP6. Two putative orthologs of mammalian ribophorin I and yeast Ost1p which share \<50% amino acid identity to each other are present in *A. thaliana* but these OST1 candidates have not been functionally characterized yet and their involvement in N-glycosylation remains to be examined. Amino acid sequence comparison between *A. thaliana* proteins and *S. cerevisiae* subunits reveals that the catalytic STT3A/STT3B subunits are better conserved in plants than all the other putative subunits (Table [I](#CWW023TB1){ref-type="table"}). Nonetheless, a prediction of the protein topologies suggests that they are highly similar between species (Figure [2](#CWW023F2){ref-type="fig"}B). Based on these data, it is therefore possible that some OST subunits have a conserved role in the complex while others might have a different function in plants. Further insights into OST function await the purification of the complex, identification of the subunit composition and subsequent biochemical characterization.

*N*-Glycan processing in the ER of plants {#s4}
=========================================

Upon transfer of the Glc~3~Man~9~GlcNAc~2~ oligosaccharide to the asparagine residue of a nascent polypeptide chain, the *N*-glycan is processed in the lumen of the ER. Like in other eukaryotes, the first trimming reactions are performed by α-glucosidases I (GCSI) and α-glucosidases II (GCSII) which remove the outermost two Glc residues. Before being subjected to further processing, incompletely folded glycoproteins with mono-glucosylated glycans can be captured by the ER resident lectins calnexin (CNX) and calreticulin. As part of a conserved quality control process, this specific lectin--glycan interaction prevents aggregation of folding intermediates and promotes folding of glycoproteins ([@CWW023C16]). In mammals, Glc trimming by GCSII releases the protein from CNX/calreticulin, while re-glucosylation by the folding sensor UDP-Glc glycoprotein glucosyltransferase (UGGT) enables again the interaction with CNX/calreticulin. Glycoproteins that attain their final conformation are no longer recognized by UGGT and allowed to exit the ER to downstream compartments (Figure [3](#CWW023F3){ref-type="fig"}). Fig. 3.*N*-Glycan processing and *N*-glycan-mediated quality control in the ER of plants. The OST complex transfers the assembled *N*-glycan precursor to accessible Asn residues within the glycosylation consensus sites of nascent polypeptides. The first *N*-glycan processing step is carried out by α-glucosidase I (GCSI). Upon trimming of another terminal Glc residue by GCSII, the protein with a mono-glucosylated *N*-glycan may enter the calnexin (CNX)/calreticulin cycle. Proper folded glycoproteins are released from the quality control process and can exit the ER. Aberrant glycoproteins that cannot attain their final conformation are sent for degradation by the ERAD pathway which requires MNS4/MNS5-mediated Man trimming and recognition by OS9. The class I α-mannosidase MNS3 hydrolyses a single α1,2-Man residue from the middle branch (B-branch see also Figure [2](#CWW023F2){ref-type="fig"}A) of the oligomannosidic *N*-glycan. MNS3 may act on folded as well as on partially folded glycoproteins. The subcellular site of MNS3 action is still obscure. While MNS3 has so far been exclusively found in Golgi-like structures ([@CWW023C70]), ER-resident glycoproteins display *N*-glycans that have been trimmed by the MNS3-like ER-α-mannosidase activity. This figure is available in black and white in print and in color at *Glycobiology* online.

GCSI activity is essential for plants and mutants with weak *gcsI* alleles display severe growth defects ([@CWW023C12]; [@CWW023C34]; [@CWW023C30]; [@CWW023C141]) (Table [II](#CWW023TB2){ref-type="table"}). However, these defects can be suppressed by additional knockout of the α1,2-glucosyltransferase ALG10 ([@CWW023C27]), indicating that trimming of the outermost Glc is a prerequisite for further processing by GCSII. Plant GCSII occurs very likely as a luminal hetero-dimeric protein consisting of the catalytic α-subunit (GCSIIα) and the Man-6-phosphate receptor homology domain-containing β-subunit (GCSIIβ) ([@CWW023C57]; [@CWW023C117]). Despite several attempts, *gcsIIα* null mutants could not be obtained so far, suggesting that the GCSIIα-mediated Glc trimming reactions are essential for plants ([@CWW023C15]; [@CWW023C117]). Weaker alleles of *gcsIIα* or plants with reduced GCSIIα expression are viable, but display severe developmental defects ([@CWW023C132]; [@CWW023C15]). In contrast, GCSIIβ-deficient plants lack any phenotype under normal growth conditions. Nonetheless, GCSIIβ is required for proper EFR biogenesis and *gcsIIβ* plants display changes in defense signaling and plant immunity ([@CWW023C76]; [@CWW023C139]). Given the central role of UGGT in ER quality control processes in mammals ([@CWW023C81]), it is surprising that *A. thaliana* plants deficient for the single UGGT isoform are viable and do not display any obvious growth or developmental phenotype ([@CWW023C51]). In view of the essential role of GCSII, it is possible that a single CNX/calreticulin interaction is sufficient to achieve proper folding of the important plant glycoproteins. However, another study suggests that *A. thaliana* with either no or low UGGT expression are impaired in their growth and more sensitive towards biotic and abiotic stress treatments which contradicts the previous findings ([@CWW023C10]). In addition, different genetic screens have identified *A. thaliana* lines with mutations in the gene coding for UGGT ([@CWW023C51]; [@CWW023C69]; [@CWW023C104]; [@CWW023C148]). These studies demonstrate that UGGT is critical for the biogenesis of a mutant variant of BRASSINOSTEROID INSENSITIVE1 (BRI1-9), EFR and SUPPRESSOR OF BIR1,1 (SOBIR1), which are all glycosylated receptor-like kinases. Further studies are needed to solve the reported discrepancy of UGGT function and to better understand its role for glycan-mediated quality control. Table II.Overview of plant *N*-glycan processing mutants and their phenotypesProteinLocusMutantPhenotypeReference*A. thaliana*\
GCSI\
(MOGS)^a^\
At1g67490\
\
\
*gcsI*\
*knf14*\
*knf101*\
Embryo lethal\
Embryo lethal\
Hypomorphic allele, growth phenotype\
[@CWW023C12]\
[@CWW023C34]\
[@CWW023C30]GCSII α\
(GANAB)At5g63840\
\
*rsw3*\
*psl5-1*Hypomorphic allele, temperature-sensitive root growth phenotype\
Hypomorphic allele, defect in EFR biogenesis, altered plant immunity[@CWW023C15]\
[@CWW023C76]GCSII β\
(GLU2B)At5g56360*gcsIIβ*\
*psl4-1*\
*psl4-2*Impaired plant immunity against bacteria, defect in EFR biogenesis, altered plant immunity[@CWW023C139]\
[@CWW023C76]MNS3\
(MAN1B1)At1g30000*mns3*Enhanced growth phenotype in the *mns3 rsw2-1*^b^ double mutant[@CWW023C70]MNS1\
MNS2\
(MAN1A1)\
(MAN1A2)\
(MAN1C1)At1g51590\
At3g21160*mns1 mns2*\
\
*mns1 mns2 mns3*Double mutant displays a conditional root phenotype; severe growth defect in the *mns1 mns2 rsw2-1* triple mutant\
Triple mutant displays root and shoot growth phenotype[@CWW023C70]\
[@CWW023C71]\
[@CWW023C70]GnTI\
(MGAT1)\
GMII\
(MAN2A1)\
GnTII\
(MGAT2)\
XYLT\
FUT11\
FUT12\
\
\
GALT1\
\
FUT13\
*O. sativa*\
GCSI\
(MOGS)\
GnTI\
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\
At5g14950\
\
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\
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\
\
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\
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\
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\
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\
Os08g0503800*cgl1 C5*\
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*hgl1-1*\
\
*gntII*\
\
*xylt*\
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\
*fut11 fut12 xylt*\
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\
*fut13*\
\
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\
*gnt1*\
\
*rcn11*Increased sensitivity towards salt stress, enhanced growth phenotype in the *gntI rsw2-1* double mutant\
Increased sensitivity towards salt stress, enhanced root growth phenotype in the *hgl1 rsw2-1* double mutant\
No described phenotype\
\
No described phenotype\
No described growth phenotype, root growth phenotype in the *fut11 fut12 rsw2-1* triple mutant\
Increased sensitivity towards salt stress\
Increased salt sensitivity compared with *hgl1*\
No described phenotype\
\
No described phenotype\
\
Hypomorphic allele, defect in root cell division and root elongation\
\
Severe growth defects, early lethality, no reproduction\
\
Affects vegetative growth under low-temperature conditions[@CWW023C55]\
\
[@CWW023C55]\
[@CWW023C100]\
[@CWW023C145]\
[@CWW023C100]\
[@CWW023C118]\
[@CWW023C118]\
[@CWW023C100]\
[@CWW023C55]\
[@CWW023C56]\
[@CWW023C121]\
[@CWW023C125] unpublished\
[@CWW023C141]\
\
[@CWW023C25]\
\
[@CWW023C128][^2][^3]

The next *N*-glycan processing step is the removal of a single α1,2-linked Man from the middle branch (B-branch, Figure [2](#CWW023F2){ref-type="fig"}A) of the oligosaccharide. The class I α-mannosidase MNS3 displays this typical ER-α-mannosidase I activity in *A. thaliana* ([@CWW023C70]). MNS3-deficient plants produce considerable amounts of incompletely processed *N*-glycans and minor amounts of complex *N*-glycans. The majority of these *N*-glycans carry the terminal α1,2-linked Man on the B-branch providing further evidence that MNS3 activity is responsible for this trimming reaction ([@CWW023C70]). *N*-Glycan analysis and enzymatic assays have demonstrated that *A. thaliana* β1,2-*N*-acetylglucosaminyltransferase I (GnTI) is able to transfer a single GlcNAc residue to this uncommon acceptor substrate. Together with further processing by other Golgi-resident enzymes, a number of aberrant complex *N*-glycans are generated in the *mns3* mutant which are well tolerated and do not affect plant development. However, genetic interaction analysis shows a strong synergistic effect between the MNS3 loss-of-function mutant and *rsw2-1* a weak allele of the *KORRIGAN1* gene ([@CWW023C70]). A similar additive effect was observed when mannosidase trimming was blocked in the partial loss-of-function mutant *cob-1*, which has a mutation in the gene coding for the *A. thaliana* glycoprotein COBRA ([@CWW023C70]). A weaker, but still discernible phenotype enhancement was also detected for a null mutant of the cellulose synthase catalytic subunit 6, which is very likely not N-glycosylated. Collectively, current data suggest that MNS3 and other α-mannosidases are required for the *N*-glycan processing of one or more glycoproteins involved in cellulose/cell wall biosynthesis.

Strikingly and in sharp contrast to the corresponding yeast ortholog, MNS3 does not display any ER location and fluorescently labelled MNS3 is found in puncta resembling Golgi-like structures ([@CWW023C70]). *N*-Glycans from ER-resident proteins display substantial amounts of Man~8~GlcNAc~2~ structures ([@CWW023C92]; [@CWW023C125]), indicating that these proteins have been processed by MNS3, the only known plant α-mannosidase that can efficiently hydrolyze this Man residue in plants. How can this puzzle be explained? At steady state, MNS3 may have a dual localization in plants with the majority of MNS3 in Golgi-like structures and only a very minor fraction concentrated in the ER where it trims Man residues from the B-branch of glycoproteins. Alternatively, MNS3 may be either completely absent from the ER and concentrated in the Golgi or at the ER-Golgi interface. In this scenario, substrate glycoproteins including ER-resident proteins cycle from the ER to the MNS3 compartment for processing and back to the ER. Although initially found in the ER ([@CWW023C102]; [@CWW023C36]), mammalian ER-α-mannosidase I has been proposed to reside in the Golgi ([@CWW023C93]; [@CWW023C48]) and/or in so-called ER-derived quality control vesicles ([@CWW023C9]). In plants, such vesicles or a dedicated quality control compartment have not been identified. Advanced cell biological studies including high-resolution imaging technologies are required to determine the precise MNS3 location in plant cells. Hopefully, these insights will also shed more light on the functional relevance of this uncommon subcellular compartmentation in plants.

Apart from *N*-glycan processing, yeast and human ER-α-mannosidase I play also a critical role for the disposal of terminally misfolded glycoproteins by the ER-associated degradation (ERAD) pathway. In *S. cerevisiae* the trimming by Mns1p is required for further processing by Htm1p. This stepwise Man removal process leads to the formation of an oligomannosidic glycan with an exposed α1,6-linked Man residue that serves as the glycan signal for degradation of aberrant glycoproteins ([@CWW023C19]). Plants have a similar ERAD pathway ([@CWW023C75]), but genetic evidence indicates that *A. thaliana* MNS3 is dispensable for the disposal of membrane-anchored or luminal glycoprotein ERAD substrates ([@CWW023C46]; [@CWW023C47]). While the *N*-glycan processing by MNS3 and Golgi-α-mannosidases is apparently not a prerequisite for ERAD of misfolded glycoproteins in *A. thaliana*, the activity of two other class I α-mannosidases, MNS4 and MNS5 is crucial to produce the glycan degradation determinant ([@CWW023C47]). The generated *N*-glycan is subsequently recognized by the Man-6-phosphate receptor homology domain-containing lectin OS9 and other components of the ERAD pathway such as HRD3/SEL1L ([@CWW023C126], [@CWW023C127]; [@CWW023C45]). Although the molecular mechanisms for terminal α1,6-linked Man formation and recognition are in principle conserved between eukaryotic species, the *N*-glycans of plant ERAD substrates display considerable amounts of mono-glucosylated structures ([@CWW023C46]; [@CWW023C47]) (Figure [3](#CWW023F3){ref-type="fig"}). The significance of this difference is unclear, but it is plausible that the CNX/calreticulin cycle and the ERAD machinery interact very closely in plants. Targeting of misfolded glycoproteins for disposal might include a so far uncharacterized step in the quality control and degradation pathway. Whether such an alternative scenario is specific for plants or a more common feature of glycoprotein ERAD remains to be shown. Removal of the Man from the A-branch (Figure [2](#CWW023F2){ref-type="fig"}A) has been proposed to be an important step during quality control and ERAD of misfolded glycoproteins in mammals as it prevents re-glucosylation by UGGT ([@CWW023C3]). However, a recent study reports that mono-glucosylated proteins can be sent for degradation in mammalian cells similar to the observations for plant ERAD substrates ([@CWW023C130]). Another open question related to glycan-dependent ERAD is the recognition process of terminally misfolded glycoproteins and the separation from proteins that are still capable of proper folding. Here, MNS4 and MNS5 may be involved, for instance, together with protein disulfide isomerases the α-mannosidases may act as sensors to discriminate between immature folding intermediates and terminally misfolded glycoproteins ([@CWW023C32]).

Apart from degradation of misfolded glycoproteins, the physiological role of glycan-dependent ERAD is currently unknown in plants and no endogenous glycoprotein or biosynthetic pathway regulated by glycan-dependent ERAD has been discovered. Plants lacking MNS4/MNS5 or other ERAD components do not display any obvious phenotype under normal growth conditions, but are markedly more sensitive to salt stress and ER stress causing agents like tunicamycin ([@CWW023C74]; [@CWW023C45]; [@CWW023C47]; [@CWW023C127]).

Complex *N*-glycan formation and function in plants {#s5}
===================================================

The first *N*-glycan processing step in the Golgi is performed by Golgi α1,2-mannosidase I, which removes three Man residues from Man~8~GlcNAc~2~ to produce Man~5~GlcNAc~2~, the substrate for the subsequent formation of hybrid and complex *N*-glycans. The two *A. thaliana* Golgi α-mannosidases, MNS1 and MNS2, are probably the result of a recent genome duplication event in *A. thaliana* and have redundant function ([@CWW023C70]). Like the soybean ortholog they are located in early Golgi cisternae and display the characteristic enzymatic features of class I α-mannosidases like sensitivity to class I α-mannosidase inhibitors kifunensine and 1-deoxymannojirimycin ([@CWW023C83]; [@CWW023C70]; [@CWW023C53]; (Figure [4](#CWW023F4){ref-type="fig"}A). Fig. 4.(**A**) Complex *N*-glycan formation in the Golgi apparatus. Terminal Man residues are removed by class I α-mannosidases (MNS1-3). Man~5~GlcNAc~2~ is used by β1,2-*N*-acetylglucosaminyltransferase I (GnTI, highlighted in bold) to initiate complex *N*-glycan formation. The different *N*-glycan processing enzymes required for the maturation of complex *N*-glycans in the Golgi are shown. Note, possible cargo transport processes mediated by cisternal maturation, vesicular transport or tubular connections are not indicated. Dependent on the mode of cargo transport there are differences in localization and retention of glycosylation enzymes. (**B**) Schematic illustration of a Golgi-resident *N*-glycan processing enzyme. The structure of the catalytic domain from rabbit GnTI ([@CWW023C136]) is illustrated with N-terminal regions representing the short cytoplasmic tail, the single transmembrane domain and the stem region. (**C**) Golgi-resident glycosyltransferases may form homomeric or heteromeric complexes that could be important for concentration of the enzymes in different Golgi cisternae and/or for the modulation of their enzymatic activities. The arrow indicates that tobacco GnTI interacts through its stem region ([@CWW023C108]). This figure is available in black and white in print and in color at *Glycobiology* online.

The formation of complex and hybrid *N*-glycans is initiated by GnTI, which transfers a single GlcNAc residue to the α1,3-linked Man of the Man~5~GlcNAc~2~ acceptor substrate to create GlcNAcMan~5~GlcNAc~2~ ([@CWW023C140]; [@CWW023C123]). Similar to animals, the GlcNAc transferred by GnTI is absolutely required for all subsequent *N*-glycan processing steps in the Golgi. Due to its central role in the pathway numerous studies have focused on the characterization of its biochemical characteristics, subcellular localization and physiological function. * Arabidopsis thaliana* mutants lacking GnTI activity were initially isolated from a pool of EMS mutagenized seeds ([@CWW023C140]). These *complex glycan 1* (*cgl1*) mutants do not produce complex *N*-glycans, when cultivated under normal growth conditions, but one of the characterized *cgl1* alleles can be suppressed in plants with reduced N-glycosylation efficiency ([@CWW023C29]; [@CWW023C27]). More recently a T-DNA insertional mutant in the GnTI gene has been described (*cgl1-T* or *gntI*) ([@CWW023C29]). Apart from slight differences during development (e.g. longer flowering time) ([@CWW023C140]; [@CWW023C14]) these GnTI-deficient *A. thaliana* do not display any phenotype under normal growth conditions. However, the *cgl1* plants display hypersensitivity towards salt stress ([@CWW023C55]), which is similar to the salt sensitivity of the OST mutant *stt3a-2*. In summary, the findings for *A. thaliana* GnTI-deficient plants suggest that complex *N*-glycans are not essential for their survival, which is in contrast to the embryo lethal phenotype of GnTI knockout mice ([@CWW023C49]; [@CWW023C79]). Recently, a GnTI T-DNA insertional mutant lacking complex *N*-glycans has been characterized from *Oryza sativa*. The rice *gnt1* mutant displays severe defects in organ development that are accompanied by problems in reproduction ([@CWW023C25]). Although the authors have not succeeded in complementation of the *gnt1* line, it is very likely that GnTI activity and complex *N*-glycans are essential for rice plants. Based on this new finding, it is plausible that other plant species will also display severe developmental defects when complex *N*-glycan formation is completely blocked.

Immediately after GnTI action, alternative processing reactions can take place in plants because GlcNAcMan~5~GlcNAc~2~ serves as substrate for at least three different *N*-glycan processing enzymes ([@CWW023C8]) (Figure [4](#CWW023F4){ref-type="fig"}A). One possible subsequent step in the plant *N*-glycan processing pathway is the cleavage of two Man residues by Golgi-α-mannosidase II (GMII). Like in other higher eukaryotes, the Man removal is followed by β1,2-*N*-acetylglucosaminyltransferase II (GnTII)-catalyzed transfer of another GlcNAc residue to the α1,6-linked Man. Alternatively, the hybrid GlcNAcMan~5~GlcNAc~2~ glycan can be modified in the *medial*-Golgi by β1,2-xylosyltransferase (XYLT) or *medial*- to *trans*-Golgi by core α1,3-fucosyltransferase. Both enzymes are ubiquitous in plants, but not present in mammals. These alternative processing routes have been postulated based on the analysis of the substrate specificity of recombinant enzymes and have been supported by the analysis of *N*-glycan structures in corresponding knockout plants ([@CWW023C124]). In agreement with data for GnTI-deficient *A. thaliana*, the characterized GMII and GnTII knockout plants do not display any obvious phenotype under normal growth conditions. However, GMII-deficient *A. thaliana* display a conditional phenotype under salt stress ([@CWW023C55]).

*Arabidopsis thaliana* contains a single XYLT enzyme capable of transferring Xyl residues to various *N*-glycan acceptor substrates in vitro and in vivo ([@CWW023C118], [@CWW023C124]; [@CWW023C8]). As mentioned before, XYLT can compete for the same substrates with core α1,3-fucosyltransferase. Two core α1,3-fucosyltransferases, FUT11 and FUT12, have been identified in *A. thaliana* and both can modify *N*-glycans in vivo in a redundant manner ([@CWW023C142]; [@CWW023C118]). The presence of two core α1,3-fucosyltransferase copies in the *A. thaliana* genome is most likely the result of a gene duplication event, which is corroborated by the fact that only a single core α1,3-fucosyltransferase gene is present in plant species like rice ([@CWW023C66]). While XYLT and FUT11/FUT12 can utilize the same acceptor *N*-glycan, preceding core α1,3-fucosylation interferes with in vitro xylosylation of *N*-glycan substrates ([@CWW023C8]). Interestingly, *N*-glycans lacking core Fuc are increased in XYLT-deficient *A. thaliana*, indicating that attachment of β1,2-Xyl enhances the rate of Fuc transfer ([@CWW023C118], [@CWW023C125]; [@CWW023C56]). The subcellular localization of core α1,3-fucosyltransferases has not been reported, but it has been suggested that core fucosylation occurs mainly in the *medial*- and *trans*-Golgi ([@CWW023C67]). Interestingly, neither the single *A. thaliana* (*xylt*, *fut11*, *fut12*), nor double (*fut11 fut12*), nor triple (*xylt fut11 fut12*) knockout lines display any obvious phenotype under normal growth conditions indicating that β1,2-Xyl and core α1,3-Fuc residues are dispensable for plant development. The absence of a visible phenotype in stable mutant lines is consistent with *N. benthamiana* plants with strongly downregulated expression of XYLT and core α1,3-fucosyltransferases ([@CWW023C125]). Under salt stress conditions no or only a very weak root growth inhibition has been detected for *A. thaliana xylt* and *fut11 fut12* but a stronger phenotype has been described for the *xylt fut11 fut12* triple mutant ([@CWW023C55]).

The last known step in the *N*-glycan processing pathway in plants is the generation of Lewis A-containing structures. Two enzymes are required for the synthesis of the Lewis A epitope on complex plant *N*-glycans ([@CWW023C67]; [@CWW023C121]). First, a β1,3-galactosyltransferase (GALT1) transfers Gal in β1,3-linkage to terminal GlcNAc residues, resulting in the synthesis of type 1 chain structures (Galβ1--3GlcNAc). In the second step, α1,4-fucosyltransferase (FUT13) transfers Fuc in α1,4-linkage to the GlcNAc of the type 1 chain to complete the synthesis of the Lewis A structure. Although the *A. thaliana* CAZy GT-31 family consists of 20 putative β1,3-galactosyltransferases, only GALT1 appears to modify *N*-glycans ([@CWW023C121]). *Arabidopsis thaliana* GALT1 is a Golgi-resident type II membrane protein with an uncommon protein architecture. GALT1 contains a putative galactoside binding lectin-domain between the N-terminal targeting/membrane anchoring region and the catalytic domain ([@CWW023C121]). A similar lectin-like domain is not found in mammalian β1,3-galactosyltransferases ([@CWW023C40]). This characteristic protein domain is also present in five other *A. thaliana* proteins, which belong to CAZy GT-31 family and display 40--73% identity to GALT1 at the amino acid sequence level ([@CWW023C121]; [@CWW023C97]). Members of this lectin-domain-containing sub-family have been recently proposed to initiate arabinogalactan biosynthesis by transfer of Gal to hydroxyprolines on arabinogalactan proteins ([@CWW023C6], [@CWW023C7]).

GALT1-deficient *A. thaliana* lack the Lewis A epitope on *N*-glycans, but display no growth or developmental defects ([@CWW023C121]). The same applies for a GALT1 overexpression line that produces increased amounts of the Lewis A epitopes on glycoproteins in different *A. thaliana* organs. A T-DNA insertional mutation in the *FUT13* gene leads to the loss of the Lewis A epitope without any effect on plant growth or development ([@CWW023C125]). The Lewis A-containing glycans are expressed in an organ-specific manner in *A. thaliana* with high amounts in stems and siliques and virtually none in leaves ([@CWW023C28]; [@CWW023C143]; [@CWW023C121]). Moreover, the epitope is not found on vacuolar proteins, but enriched at the plasma membrane and extracellular glycoproteins. *Arabidopsis thaliana* glycoproteins carrying the epitope have not been characterized. A glycoproteomics study from etiolated *A. thaliana* hypocotyls identified a single glycoprotein with a mono-antennary Lewis A-type *N*-glycan at one of its N-glycosylation sites ([@CWW023C146]). The function of this cell wall glycoprotein with homology to blue copper binding proteins has not been studied and the biological relevance of Lewis A structures on plant complex *N*-glycans is still obscure.

Apart from the formation of the Lewis A structures, no additional elongation or modification of terminal GlcNAc residues has been identified in plants. As a consequence, plants lack complex *N*-glycans with sialic acid, core α1,6-linked Fuc, β1,4-galactoslyation or branching of *N*-glycans. However, plants are able to efficiently carry out these complex *N*-glycan maturation steps when the missing enzymes and pathways are transiently or stably heterologously expressed *in planta*. Numerous glyco-engineering approaches have demonstrated that plants tolerate these modifications very well and are able to produce defined mammalian-type *N*-glycan structures in substantial amounts ([@CWW023C119]).

Are there any post-Golgi modifications of *N*-glycans? Earlier studies with common beans have shown that terminal GlcNAc residues are removed from Golgi-modified glycoproteins in the vacuole giving rise to the formation of paucimannosidic *N*-glycans ([@CWW023C138]; [@CWW023C67]). More recent data extend this view and indicate that post-Golgi processing of *N*-glycans takes place in the vacuole as well as at the plasma membrane ([@CWW023C120]; [@CWW023C72]; [@CWW023C17]). In *A. thaliana*, the specific cleavage of terminal GlcNAc residues from vacuolar glycoproteins is carried out by β-*N*-acetylhexosaminidase 1 (HEXO1). In contrast, β-*N*-acetylhexosaminidase 3 (HEXO3) has been located to the plasma membrane where it trims GlcNAc residues from secreted glycoproteins ([@CWW023C72]). While the biological functions of HEXO1 and HEXO3 are unknown, it has been shown for other plant species that β-*N*-acetylhexosaminidases are important factors for the control of fruit ripening ([@CWW023C78]).

Golgi organization of plant *N*-glycan processing enzymes {#s6}
=========================================================

An open question in plant glycobiology is the spatial organization of glycosyltransferases and glycosidases in the secretory pathway, especially in the Golgi, the site of complex *N*-glycan formation and cell wall polysaccharide synthesis. In particular, how the non-uniform distribution of Golgi-resident enzymes is achieved and maintained during constant trafficking of cargo glycoproteins is largely unknown ([@CWW023C109]). The distribution of *N*-glycan processing enzymes in a *cis/medial-*to-*trans* fashion along the different Golgi cisternae make them valuable tools to investigate the spatial organization and underlying mechanisms ([@CWW023C99]). Tobacco GnTI, the central enzyme for complex *N*-glycan maturation is a type II membrane protein. The signal for Golgi targeting and retention of tobacco GnTI is present in the so-called cytoplasmic tail, transmembrane domain and stem region ([@CWW023C110], [@CWW023C108]) (Figure [4](#CWW023F4){ref-type="fig"}B). Remarkably, the basic principles of Golgi targeting and retention appear conserved as plant and mammalian GnTI can complement each other ([@CWW023C35]; [@CWW023C5]). Moreover, the N-terminal targeting region from the *trans*-Golgi-resident rat α2,6-sialyltransferase is the most widely used *trans*-Golgi marker in plants ([@CWW023C11]). However, glyco-engineering approaches have also shown that human β1,4-galactosyltransferase 1 (B4GALT1) is targeted to a different Golgi subcompartment in plants and interferes with biantennary complex *N*-glycan formation leading to increased *N*-glycan heterogeneity ([@CWW023C4]; [@CWW023C122]). Such subtle differences in Golgi targeting and retention may be attributed to distinct mechanisms that control Golgi organization of glycosyltransferases ([@CWW023C134]). In yeast and mammalian cells, for instance, a sorting mechanism based on recognition of sequence motifs within the cytoplasmic tail of glycosyltransferases has been revealed ([@CWW023C106]; [@CWW023C135]; [@CWW023C1]; [@CWW023C95]). In plants, the corresponding binding motif as well as a homolog of the protein sorting determinant (yeast Vps74p/mammalian GOLPH3) has not been found ([@CWW023C109]), suggesting that plants may use a different localization mechanism. Another largely unexplored factor is the role of the lipid composition and membrane environment in the plant Golgi. In mammalian cells, it has been proposed that changes in lipid composition and specialized membrane microdomains lead to partitioning and sorting of membrane-anchored proteins ([@CWW023C73]).

FRET-FLIM and co-immunoprecipitation experiments have demonstrated that early Golgi *N*-glycan processing enzymes like MNS1 and GnTI can form homomeric complexes and these sequential acting enzymes interact with each other in vivo ([@CWW023C107]) (Figure [4](#CWW023F4){ref-type="fig"}C). While the biological significance of the identified protein complex formation is unclear for plant *N*-glycan processing enzymes, it appears that complex formation in the Golgi is a common feature in different glycosylation pathways and organisms ([@CWW023C2]; [@CWW023C18]; [@CWW023C59]). The pectin biosynthetic galacturonosyltransferase GAUT1 is retained in the Golgi by complex formation with GAUT7 ([@CWW023C2]). The association between GAUT1 and GAUT7 proteins is mediated by covalent disulfide bonds and non-covalent interactions. A specific protein--protein interaction may fine-tune enzyme activity ([@CWW023C37]) or alternatively, provide a common mechanism for Golgi retention or recycling of enzymes that act together in the same biosynthetic pathway ([@CWW023C89]). On the other hand, recent data from complementation studies of GnTI-deficient plants with different chimeric GnTI variants suggests that efficient complex *N*-glycan formation in *A. thaliana* is possible without homo- or hetero-dimer formation ([@CWW023C108]). Clearly, many fundamental questions related to the Golgi organization of *N*-glycan processing enzymes are unsolved in plants and more emphasis should be given to cell biological aspects of protein glycosylation which are essential to understand the complex regulation of glycan modifications in all higher eukaryotes.

Are complex *N*-glycans required for the function of the plant glycoprotein KORRIGAN1? {#s7}
======================================================================================

As mentioned before, there is not much known about the role of complex *N*-glycans for distinct plant glycoproteins. The *A. thaliana* endo-1,4-β-[d]{.smallcaps}-glucanase KORRIGAN1 (KOR1) is a membrane-anchored glycoprotein involved in cellulose biosynthesis ([@CWW023C86]). The KOR1 partial loss-of-function mutant *rsw2-1* displays a temperature-sensitive root growth phenotype ([@CWW023C64]). Interestingly, GnTI-deficiency strongly enhances the *rsw2-1* root growth phenotype even at the permissive temperature ([@CWW023C55]). A similar additive phenotype with severe developmental defects has been observed for *mns3 rsw2-1* and *mns1 mns2 rsw2-1* mutants that harbor mainly oligomannosidic *N*-glycans ([@CWW023C70], [@CWW023C71]). These findings suggest that one or several of the eight *N*-glycans from KOR1 require complex *N*-glycans. Mass spectrometry and immunoblots has revealed that KOR1 carries oligomannosidic as well as complex *N*-glycans and heterologous expression of KOR1 variants lacking individual N-glycosylation sites in insect cells has demonstrated that N-glycosylation is important for in vitro enzyme activity ([@CWW023C151]). However, a recombinant KOR1 variant with essentially oligomannosidic *N*-glycans displays a comparable in vitro activity like KOR1 with complex *N*-glycans. In another study, it has been shown that KOR1 lacking all eight N-glycosylation sites is still able to partially complement the root growth phenotype of *gntI rsw2-1* plants ([@CWW023C100]). In summary, both studies independently conclude that complex *N*-glycans are very likely not directly required for KOR1 function. Thus, an unknown glycoprotein with complex *N*-glycans and involvement in cellulose synthesis appears affected in these plants and causes the observed additive phenotype. Further genetic evidence shows that GMII-deficiency as well as the absence of core Fuc also enhances the *rsw2-1* phenotype ([@CWW023C100]). On the other hand, GnTII-deficiency or the lack of Lewis A epitope formation does not lead to an additional phenotypic effect. Future genetic and biochemical studies should aim to identify this unknown glycoprotein with a functional complex *N*-glycan structure in plants.

Conclusion and future perspectives {#s8}
==================================

The *N*-glycan processing pathway in plants is quite well understood and all enzymatic steps leading to the formation of the known *N*-glycan structures have been investigated. However, even from the model plant *A. thaliana* a comprehensive *N*-glycan profiling of different organs and cell types has not been reported and information on *N*-glycan maturation steps in different plant species is incomplete. Intriguingly, studies of the *A. thaliana* Golgi proteome revealed numerous Golgi-resident glycosyltransferases of unknown function ([@CWW023C88]; [@CWW023C94]). While most of them are very likely involved in the biosynthesis of different cell wall polysaccharides or complex O-glycosylated proteins like arabinogalactan proteins it cannot be excluded that some of these enzymes generate rare modifications on *N*-glycans. In comparison to mammals, our understanding of *N*-glycan function is very limited in plants. Data for *A. thaliana* and for monocots like rice strongly indicate that complex *N*-glycans are crucial for correct growth under stress conditions. The recent identification of rice XYLT-deficient plants with significant growth defects at low temperature is one example ([@CWW023C128]). The complete sequencing of different plant genomes and the availability of straightforward genome editing technologies will pave the way for efficient modifications of *N*-glycan processing reactions in many plant species within a reasonable time frame ([@CWW023C98]). Likewise, these editing tools can be applied to introduce mutations into the genome that remove N-glycosylation sites from individual glycoproteins in order to investigate the biological role of distinct *N*-glycans under different environmental conditions. As a consequence of these revolutionary developments novel functions of plant *N*-glycans will be revealed soon.
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[^1]: No homolog of the yeast Ost5p subunit has been identified in the *A. thaliana* genome. The amino acid identity between DAD1 and DAD2 is ∼95% and OST4A/OST4B share ∼88% identity. In contrast, the amino acid identity of OST1A and OST1B to each other is \<50%, suggesting that they represent two OST1 isoforms with little or only partially overlapping function.

[^2]: ^a^For conserved enzymes, abbreviations according to the Human Genome Nomenclature Committee are given in parentheses.

[^3]: ^b^*rsw2-1* is a partial loss-of-function mutant of *KORRIGAN1*.
